These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26826434)

  • 21. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
    Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunology of systemic sclerosis.
    Artlett CM
    Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systemic sclerosis.
    Asano Y
    J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleroderma.
    Gilliam AC
    Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global hypomethylation pattern in systemic sclerosis: An application for absolute quantification of epigenetic DNA modification products by 2D-UPLC-MS/MS.
    Dal-Bekar NE; Siomek-Gorecka A; Gackowski D; Köken-Avşar A; Yarkan-Tuğsal H; Birlik M; İşlekel H
    Clin Immunol; 2022 Jun; 239():108997. PubMed ID: 35398518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
    Thachil J
    Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.
    Yoshizaki A; Taniguchi T; Saigusa R; Fukasawa T; Ebata S; Numajiri H; Nakamura K; Yamashita T; Takahashi T; Toyama T; Asano Y; Tedder TF; Sato S
    Ann Rheum Dis; 2016 Oct; 75(10):1858-65. PubMed ID: 26567180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature.
    Giuggioli D; Lumetti F; Colaci M; Fallahi P; Antonelli A; Ferri C
    Autoimmun Rev; 2015 Nov; 14(11):1072-8. PubMed ID: 26209905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of genetics and epigenetics in the pathogenesis of systemic sclerosis.
    Broen JC; Radstake TR; Rossato M
    Nat Rev Rheumatol; 2014 Nov; 10(11):671-81. PubMed ID: 25136786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.
    Cabral-Marques O; Riemekasten G
    Autoimmun Rev; 2016 Jul; 15(7):690-4. PubMed ID: 26970493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic susceptibility to systemic sclerosis from clinical aspect to genetic factor analyses.
    Granel B; Bernard F; Chevillard C
    Eur J Intern Med; 2009 May; 20(3):242-52. PubMed ID: 19393491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic sclerosis. Part 2. Epigenetic factors in the pathogenesis of clinical manifestations].
    Fryc J; Midro AT; Panasiuk B; Sierakowski S
    Przegl Lek; 2015; 72(1):25-30. PubMed ID: 26076574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New developments in the pathogenesis of systemic sclerosis.
    Sakkas LI
    Autoimmunity; 2005 Mar; 38(2):113-6. PubMed ID: 16040330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
    Luo Y; Xiao R
    Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets.
    Mahler M; Hudson M; Bentow C; Roup F; Beretta L; Pilar Simeón C; Guillén-Del-Castillo A; Casas S; Fritzler MJ
    Autoimmun Rev; 2020 Aug; 19(8):102583. PubMed ID: 32553611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis.
    Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Dermatol Sci; 2005 Jul; 39(1):1-7. PubMed ID: 15885984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NRAMP1 (SLC11A1): a plausible candidate gene for systemic sclerosis (SSc) with interstitial lung involvement.
    Ates O; Müsellim B; Ongen G; Topal-Sarikaya A
    J Clin Immunol; 2008 Jan; 28(1):73-7. PubMed ID: 17876529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.